首页> 外文期刊>Clinical nuclear medicine >Clinical impact of SPECT/CT with In-111 biotin on the management of patients with suspected spine infection.
【24h】

Clinical impact of SPECT/CT with In-111 biotin on the management of patients with suspected spine infection.

机译:SPECT / CT和In-111生物素对疑似脊柱感染患者管理的临床影响。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Early identification and localization of spine infection is necessary for adequate therapeutic strategy. To localize the precise site of infection we evaluated In-111 Biotin SPECT/CT versus planar and SPECT imaging. METHODS: Seventy-two consecutive patients were enrolled and underwent SPECT/CT and planar imaging 2 to 4 hours post i.v. injection of In-111 Biotin. Final diagnosis was based on bacterial cultures and/or clinical/imaging follow-up for at least 1 year. We evaluated the diagnostic performance of planar, SPECT, and SPECT/CT In-111 Biotin scintigraphy. RESULTS: In-111 Biotin SPECT/CT and SPECT showed similar values of sensitivity (93.5% vs. 92.1%) and the same specificity (92.3%), planar imaging showed 80.4% of sensitivity and 69.2% of specificity. In 16 patients SPECT/CT correctly localized the infection site (bone, soft tissue, or both bone and soft tissue). CONCLUSIONS: SPECT/CT enhances the impact of In-111 Biotin scintigraphy on the clinical management of patients, allowing the exact site of infection to be localized to select the appropriate therapy.
机译:目的:脊柱感染的早期识别和定位对于适当的治疗策略是必要的。为了定位精确的感染部位,我们评估了In-111生物素SPECT / CT与平面和SPECT成像的对比。方法:连续入组72例患者,在静脉注射后2至4小时接受SPECT / CT和平面成像。注射In-111生物素。最终诊断基于细菌培养和/或临床/影像学随访至少一年。我们评估了平面,SPECT和SPECT / CT In-111生物素闪烁显像的诊断性能。结果:In-111生物素SPECT / CT和SPECT显示出相似的灵敏度值(93.5%比92.1%)和相同的特异性(92.3%),平面成像显示出80.4%的灵敏度和69.2%的特异性。在16例患者中,SPECT / CT正确地定位了感染部位(骨,软组织或骨和软组织)。结论:SPECT / CT增强了In-111生物素闪烁显像技术对患者临床治疗的影响,可以确定确切的感染部位以选择合适的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号